Table 9.
Hyperlactatemia (HL) during cardiopulmonary bypass and postoperative outcome
| Variable | Group A (n = 250) |
Group B (n = 250) |
||
|---|---|---|---|---|
| No HL (n = 235; 94%) | HL (n = 15; 6%) | No HL (n = 208; 83.2%) | HL (n = 42; 16.8%) | |
| Peak serum creatinine (mg/dL) | 1.1 ± 1.0 | 1.9 ± 1.5 | 1.2 ± 1.1 | 1.9 ± 1.5 |
| MV time (h) | 20.6 ± 45 | 54 ± 49 | 23.6 ± 55 | 54 ± 49 |
| ICU stay (d) | 2.8 ± 2.1 | 5.7 ± 4.9 | 3.1 ± 2.1 | 6.4 ± 3.9 |
Values are presented as mean ± standard deviation. HL, Hyperlactatemia; MV, mechanical ventilation; ICU, intensive care unit.